System 04 · ~8% of exam

Renal & GU

AKI by pre/intra/post-renal. CKD staging and its complications. Electrolytes by mechanism. Acid-base by systematic approach. Hematuria by glomerular vs non-glomerular.

Chief complaints

BUILD THE DIFFERENTIAL

Vignettes enter through one of these doors. Each complaint lays out the full differential, marks the can't-miss diagnoses, and tells you the next right action for each.

Acute kidney injuryHematuriaHyperkalemiaHyponatremia
CHIEF COMPLAINT · HIGH-YIELD

Acute kidney injury

Pre-renal, intra-renal, post-renal. Fractional excretion of sodium and urine microscopy separate them.

AKI = rise in Cr ≥ 0.3 in 48 hr or ≥ 1.5× baseline. Pre-renal: volume depletion, HF, cirrhosis, sepsis (FeNa < 1%). Intra-renal: ATN, AIN, glomerulonephritis (FeNa > 2%). Post-renal: obstruction (bladder scan, renal US).

Diagnosis Key features / clues Next step
Pre-renal azotemia Volume depletion (vomiting, diarrhea, diuretics), HF, cirrhosis. BUN/Cr > 20. FeNa < 1%. IV fluids · treat underlying cause
Acute tubular necrosis Ischemic (prolonged pre-renal) or toxic (contrast, aminoglycosides, cisplatin, rhabdo). Muddy brown casts. FeNa > 2%. Supportive · remove offending agent · dialysis if AEIOU indication
Acute interstitial nephritis Drug reaction (NSAIDs, PPIs, penicillins, sulfas). Rash, fever, eosinophilia (classic triad), WBC casts, urine eosinophils. Stop offending drug · steroids if severe
Rhabdomyolysis Crush injury, prolonged immobilization, statins, seizure. CK > 5× upper limit. Tea-colored urine, dipstick positive for blood but no RBCs. Aggressive IV fluids · urine alkalinization (controversial) · watch K
Post-renal obstruction Older male with BPH, stones, malignancy. Oliguria or anuria. Bladder scan · renal US · relieve obstruction (Foley, nephrostomy, etc.)
Contrast-induced nephropathy Rise in Cr 24–72 hr after contrast. Risk: CKD, DM, volume depletion. IV fluids pre-procedure (normal saline or isotonic bicarb) · minimize contrast
Rapidly progressive glomerulonephritis Hematuria, red cell casts, rising Cr over days to weeks, hypertension. Renal biopsy · treatment depends on cause (anti-GBM, ANCA, immune complex)
= can't-miss diagnosis · rule out first
Exam-style stem
A 72-year-old man 3 days after coronary angiography has a rise in Cr from 1.1 to 2.4. BP 128/72. Urine output adequate. UA: hyaline casts.
Most likely diagnosis?
Answer › Contrast-induced nephropathy. Peaks at 3–5 days. Supportive care, hold nephrotoxins, ensure volume status. Usually resolves within 1–2 weeks.
Pearl
AEIOU indications for dialysis: severe Acidosis, Electrolyte abnormalities (K > 6.5 refractory), Ingestion (toxic alcohol, lithium, salicylates), Overload (refractory), Uremia (pericarditis, encephalopathy, bleeding).
Pearl
Urine microscopy is the cheapest, most high-yield test in AKI. Muddy brown casts (ATN), WBC casts (pyelo or AIN), RBC casts (GN), eosinophils (AIN), hyaline casts (pre-renal).
Pearl
If AKI doesn't improve with fluids and there's no obstruction, the kidney is the problem. Urine microscopy and consider biopsy.
CHIEF COMPLAINT

Hematuria

Glomerular (RBC casts, dysmorphic RBCs, proteinuria) vs non-glomerular (normal RBCs, no casts).

Glomerular: GN, IgA nephropathy, Alport, thin basement membrane. Non-glomerular: stones, infection, malignancy, trauma, BPH. Painless hematuria in an older patient is bladder cancer until proven otherwise. Cystoscopy.

Diagnosis Key features / clues Next step
Bladder/urothelial cancer Painless hematuria, older smoker, occupational exposure (aniline dyes). CT urogram · cystoscopy
Renal cell carcinoma Flank pain + hematuria + mass (classic but late triad). Paraneoplastic syndromes. CT abdomen with contrast · nephrectomy
Nephrolithiasis Severe colicky flank pain radiating to groin, hematuria. Non-contrast CT abdomen · analgesia · medical expulsive therapy (alpha blocker)
IgA nephropathy Gross hematuria within days of URI. Young patient. Renal biopsy if persistent · ACEi for proteinuria
UTI / pyelonephritis Dysuria, frequency, urgency, suprapubic pain. Pyelo: flank pain, fever. UA · urine culture · antibiotics
Post-strep glomerulonephritis Child, 2–4 wk after strep throat or impetigo. Hematuria, HTN, edema, low C3. Supportive · usually self-limited
= can't-miss diagnosis · rule out first
Pearl
A dipstick positive for blood with no RBCs on microscopy is myoglobin (rhabdo) or hemoglobin (hemolysis). Check CK and haptoglobin.
Pearl
Painless gross hematuria in any adult over 35 needs cystoscopy. Do not accept 'probably a UTI' as the answer.
Pearl
Red urine is not always blood. Pigments from beets, rifampin, phenazopyridine. Dipstick differentiates.
CHIEF COMPLAINT · HIGH-YIELD

Hyperkalemia

The ECG changes are the emergency, not the number. Stabilize the membrane first.

Causes: pseudo (hemolysis from the draw), renal failure, ACEi/ARB/spironolactone, cell lysis (rhabdo, tumor lysis), adrenal insufficiency, acidosis. ECG: peaked T waves → PR prolongation → QRS widening → sine wave → VF.

Diagnosis Key features / clues Next step
Life-threatening hyperkalemia (K > 6.5 or ECG changes) Peaked T waves, widened QRS, sine wave. Renal failure, meds, cell lysis. Calcium gluconate (stabilize membrane) → insulin + glucose, albuterol, bicarb if acidotic (shift) → furosemide, kayexalate, patiromer, dialysis (remove)
Renal failure Elevated Cr, oliguria. Treat K, dialysis if AEIOU
Medication-induced ACEi, ARB, spironolactone, NSAIDs, trimethoprim. Discontinue offending agent
Adrenal insufficiency Hyperkalemia + hyponatremia + hypotension + hypoglycemia. Weight loss, fatigue, hyperpigmentation. Random cortisol, cosyntropin stim · hydrocortisone
Tumor lysis syndrome Chemotherapy for hematologic malignancy. Hyperuricemia, hyperphosphatemia, hypocalcemia, hyperkalemia, AKI. Aggressive hydration, rasburicase or allopurinol
Pseudohyperkalemia Hemolyzed sample, severe leukocytosis or thrombocytosis. Repeat specimen properly collected
= can't-miss diagnosis · rule out first
Exam-style stem
A 70-year-old man with CKD and HF on lisinopril and spironolactone has K 6.8. ECG: peaked T waves, QRS 140 ms.
Next step?
Answer › IV calcium gluconate first to stabilize the cardiac membrane (onset in minutes, effect 30–60 min). Then insulin + glucose and albuterol to shift. Then loop diuretic, kayexalate/patiromer, or dialysis to remove. Stop ACEi and spironolactone.
Pearl
The sequence matters: STABILIZE (calcium), SHIFT (insulin, albuterol, bicarb), REMOVE (diuretic, kayexalate/patiromer, dialysis).
Pearl
Calcium gluconate does not lower potassium. It protects the myocardium while you work on the K.
Pearl
Hyperkalemia + hyponatremia + hypotension in a chronically ill patient is primary adrenal insufficiency until proven otherwise.
CHIEF COMPLAINT · HIGH-YIELD

Hyponatremia

Volume status separates the differential. Correct slowly to avoid osmotic demyelination.

Step 1: measure serum osmolality. Hypertonic (hyperglycemia, mannitol). Isotonic (pseudo, hyperlipidemia, paraproteinemia). Hypotonic: volume status. Hypovolemic: vomiting, diuretics, third-spacing. Euvolemic: SIADH, hypothyroid, adrenal insufficiency, primary polydipsia. Hypervolemic: HF, cirrhosis, nephrotic.

Diagnosis Key features / clues Next step
SIADH Euvolemic hyponatremia, low serum osm, inappropriately concentrated urine (uosm > 100, uNa > 40). Causes: CNS disease, lung disease, malignancy (SCLC), drugs. Fluid restriction · treat cause · salt tabs · tolvaptan if refractory
Hypovolemic hyponatremia Volume depletion signs, uNa < 20 (except diuretics). Isotonic saline
Hypervolemic hyponatremia Edema, HF/cirrhosis/nephrotic. Salt and water restriction · treat underlying · consider tolvaptan
Hyperglycemic pseudohyponatremia Glucose high. Corrected Na = measured Na + 1.6 × (glucose − 100)/100. Treat hyperglycemia
Beer potomania / low solute intake Low protein/solute intake, high fluid intake. Low urine osm. Nutrition · solute
Symptomatic severe hyponatremia (Na < 120 with seizures/coma) Altered mental status, seizures. 3% hypertonic saline (150 mL bolus) · raise Na by 4–6 mEq/L then stop · correct < 8 mEq/L in 24 hours
= can't-miss diagnosis · rule out first
Pearl
Correct Na by no more than 8 mEq/L in 24 hours. Faster correction → osmotic demyelination (central pontine myelinolysis).
Pearl
SIADH is a diagnosis of exclusion. Rule out hypothyroidism and adrenal insufficiency first, they mimic SIADH and missing them is harmful.
Pearl
Hypertonic saline is for neurologically symptomatic severe hyponatremia. Give a small bolus, reassess, stop at 4–6 mEq/L rise.

Disease deep dives

DEFINITIVE DX

Once you've identified the likely diagnosis from the chief complaint, these pages give you the presentation, workup, management, and exam pearls in depth.

DISEASE DEEP DIVE

Chronic Kidney Disease

Stages, complications (anemia, CKD-MBD, acidosis, HTN, CV risk), and when to refer for dialysis/transplant.

Asymptomatic early. Late: fatigue, pruritus, nausea, anorexia, edema, pericardial friction rub, asterixis.

  1. eGFR staging. G1 ≥ 90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, G5 < 15 or dialysis.
  2. Albuminuria. A1 < 30, A2 30–300, A3 > 300 mg/g. Both eGFR and albuminuria determine prognosis.
  3. Complications. CBC (anemia), Ca/Phos/PTH/vit D (CKD-MBD), bicarbonate (metabolic acidosis), lipids, glucose, BP.
  1. Slow progression. BP < 130/80 with ACEi or ARB (especially if proteinuria). SGLT2 inhibitor in diabetic and non-diabetic CKD. Finerenone in diabetic CKD. Low-protein diet in later stages.
  2. Anemia. Iron repletion first (IV if dialysis). ESA (erythropoietin) when Hb < 10 with target Hb 10–11.
  3. CKD-MBD. Phosphate binders (calcium acetate, sevelamer), active vitamin D (calcitriol), calcimimetics (cinacalcet). Avoid aluminum.
  4. Acidosis. Sodium bicarbonate when bicarb < 22.
  5. Renal replacement. Start dialysis when symptomatic uremia, fluid overload, refractory hyperkalemia, refractory acidosis, or eGFR < 10.
  6. Transplant. Best long-term outcome. Refer early (eGFR < 20).
Pearl
Every CKD patient gets an ACEi or ARB for renoprotection (unless contraindicated). SGLT2 inhibitors now standard in diabetic and non-diabetic CKD.
Pearl
Do not withhold contrast for eGFR > 30 based on CIN fear alone. Risk-benefit, with hydration.
Pearl
Pre-dialysis patients need an AV fistula placed 3–6 months before anticipated dialysis for maturation.
Exam-style stem
A 62-year-old man with DM has Cr 2.4, eGFR 28, urine ACR 450. BP 148/88.
Answer › CKD stage G4 A3. ACEi (renoprotective, slows progression), SGLT2 inhibitor (empagliflozin or dapagliflozin), optimize glycemic control, statin, BP target < 130/80. Refer to nephrology for transplant evaluation.
DISEASE DEEP DIVE

Nephritic Syndrome

Hematuria (dysmorphic RBCs, RBC casts), HTN, edema, mild proteinuria, oliguria. The differential is by mechanism.

Cola-colored urine, peripheral edema, hypertension. Elevated Cr.

  1. UA + sediment. RBC casts, dysmorphic RBCs. Proteinuria usually < 3.5 g/d.
  2. Serologies. ANCA, anti-GBM, ASO, anti-DNase B, ANA, dsDNA, complement (C3, C4), cryoglobulins, hep B/C/HIV.
  3. Renal biopsy. Often needed for definitive diagnosis.
  1. Post-strep GN. Supportive. Self-limited in most children.
  2. IgA nephropathy. ACEi for proteinuria. Steroids for rapid progression.
  3. Anti-GBM (Goodpasture). Plasmapheresis + steroids + cyclophosphamide.
  4. ANCA-associated vasculitis (GPA, MPA). Steroids + rituximab or cyclophosphamide. Plasmapheresis in severe disease.
  5. Lupus nephritis. Steroids + mycophenolate or cyclophosphamide.
Pearl
Low C3 differential: post-strep GN, MPGN, lupus nephritis, cryoglobulinemic GN. Normal C3: IgA, anti-GBM, ANCA-associated.
Pearl
IgA is the most common GN worldwide. Presents with synpharyngitic hematuria (within days of URI, not 2 weeks like post-strep).
Pearl
Pulmonary-renal syndrome: hemoptysis + nephritic → anti-GBM (Goodpasture) or ANCA-associated vasculitis (GPA).
Exam-style stem
A 20-year-old man with hemoptysis and hematuria. Cr 3.2. Anti-GBM positive. Renal biopsy: crescentic GN with linear IgG.
Answer › Goodpasture syndrome (anti-GBM disease). Plasmapheresis + high-dose steroids + cyclophosphamide.
DISEASE DEEP DIVE

Nephrotic Syndrome

Proteinuria > 3.5 g/d, hypoalbuminemia, edema, hyperlipidemia. Primary vs secondary.

Periorbital and peripheral edema, frothy urine, fatigue. Severe: anasarca, pleural effusions, ascites.

  1. Urine protein. Spot urine protein/Cr ratio or 24-hour protein.
  2. Serologies. ANA, hep B/C, HIV, SPEP/UPEP (amyloid, myeloma), complement.
  3. Renal biopsy. In adults usually needed to determine subtype.
  1. Minimal change disease. Common in children. Steroids highly effective.
  2. FSGS. Common in Black patients, HIV, obesity, heroin. Steroids + cyclosporine.
  3. Membranous. Most common primary nephrotic in adults. Associated with solid tumors, hep B, lupus, gold, penicillamine. Anti-PLA2R. Steroids + cyclophosphamide or rituximab.
  4. Diabetic nephropathy. Most common cause of nephrotic-range proteinuria overall. ACEi/ARB, SGLT2 inhibitor, glycemic and BP control.
  5. Amyloid. Biopsy with Congo red, apple-green birefringence. Treat underlying (myeloma, inflammation).
  6. Supportive. ACEi/ARB (reduce proteinuria), statin, salt restriction, diuretics, anticoagulation if severe (renal vein thrombosis risk).
Pearl
Hypercoagulability in nephrotic syndrome, especially membranous, because of urinary loss of antithrombin III. Consider prophylactic anticoagulation if severe.
Pearl
Minimal change disease is triggered by NSAIDs, Hodgkin lymphoma. Steroid-responsive in a day or two.
Pearl
FSGS in a Black patient with HIV is HIV-associated nephropathy. Collapsing variant.